These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 9598885

  • 1. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
    Vlachoyiannopoulos PG, Tzavara V, Dafni U, Spanos E, Moutsopoulos HM.
    J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
    [Abstract] [Full Text] [Related]

  • 2. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 May; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC, Barcellos KS, Andrade LE.
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [Abstract] [Full Text] [Related]

  • 4. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Jul; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 5. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
    Myckatyn SO, Russell AS.
    J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
    [Abstract] [Full Text] [Related]

  • 6. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y.
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [Abstract] [Full Text] [Related]

  • 7. Clinical utility of antinuclear antibody tests in children.
    McGhee JL, Kickingbird LM, Jarvis JN.
    BMC Pediatr; 2004 Jul 09; 4():13. PubMed ID: 15245579
    [Abstract] [Full Text] [Related]

  • 8. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
    Suarez-Almazor ME, Gonzalez-Lopez L, Gamez-Nava JI, Belseck E, Kendall CJ, Davis P.
    J Rheumatol; 1998 Oct 09; 25(10):1980-5. PubMed ID: 9779854
    [Abstract] [Full Text] [Related]

  • 9. The pathogenic 16/6 idiotype in patients with silica associated systemic lupus erythematosus (SLE) and uranium miners with increased risk for development of SLE.
    Conrad K, Levy Y, Blank M, Mehlhorn J, Frank KH, Roch B, Shoenfeld Y.
    J Rheumatol; 1998 Apr 09; 25(4):660-6. PubMed ID: 9558166
    [Abstract] [Full Text] [Related]

  • 10. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H.
    Ann Rheum Dis; 2004 Oct 09; 63(10):1250-4. PubMed ID: 15361381
    [Abstract] [Full Text] [Related]

  • 11. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
    Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM.
    Ann Rheum Dis; 2004 Sep 09; 63(9):1159-61. PubMed ID: 15308528
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
    Reichlin M, Broyles TF, Hubscher O, James J, Lehman TA, Palermo R, Stafford HA, Taylor-Albert E, Wolfson-Reichlin M.
    Arthritis Rheum; 1999 Jan 09; 42(1):69-75. PubMed ID: 9920016
    [Abstract] [Full Text] [Related]

  • 13. Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus.
    Hoffman IE, Peene I, Meheus L, Huizinga TW, Cebecauer L, Isenberg D, De Bosschere K, Hulstaert F, Veys EM, De Keyser F.
    Ann Rheum Dis; 2004 Sep 09; 63(9):1155-8. PubMed ID: 15308527
    [Abstract] [Full Text] [Related]

  • 14. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O.
    Ann Med Interne (Paris); 2002 Dec 09; 153(8):520-9. PubMed ID: 12610426
    [Abstract] [Full Text] [Related]

  • 15. [Undifferentiated connective tissue disease: clinical and serological profile of 578 patients followed for five years: disease course, prognosis and therapy].
    Bodolay E, Szegedi G.
    Orv Hetil; 2002 Feb 03; 143(5):229-33. PubMed ID: 11875835
    [Abstract] [Full Text] [Related]

  • 16. [The clinical immunology laboratory in diagnosis and monitoring of systemic lupus erythematosus and connective tissue diseases].
    Sinico RA, Radice A.
    G Ital Nefrol; 2005 Feb 03; 22 Suppl 33():S21-6. PubMed ID: 16419001
    [Abstract] [Full Text] [Related]

  • 17. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan 03; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 18. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V.
    Vnitr Lek; 1997 Oct 03; 43(10):639-44. PubMed ID: 9601876
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX, Miyamoto D, Zimbres JM, Costa DV, Aoki V.
    Clin Exp Dermatol; 2009 Apr 03; 34(3):314-8. PubMed ID: 19040522
    [Abstract] [Full Text] [Related]

  • 20. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
    Sjöwall C, Sturm M, Dahle C, Bengtsson AA, Jönsen A, Sturfelt G, Skogh T.
    J Rheumatol; 2008 Oct 03; 35(10):1994-2000. PubMed ID: 18785312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.